Overview
Jian-yong Li practices in Nanjing, China. Li is rated as an Advanced expert by MediFind in the treatment of Chromosome 13q Deletion. Their top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), B-Cell Lymphoma, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 409 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Chromosome 13q Deletion.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaLi isDistinguished. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- LeukemiaLi isDistinguished. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Li isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Advanced
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia
- Adult T-Cell Leukemia
- AgranulocytosisLi isAdvanced. Learn about Agranulocytosis.
- Chromosome 13q Deletion
- Hairy Cell Leukemia (HCL)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Adult Immune Thrombocytopenia
- ADULT SyndromeLi isExperienced. Learn about ADULT Syndrome.
- Anaplastic Large Cell Lymphoma
- AnemiaLi isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell Lymphoma